Association between bariatric surgery after kidney transplantation and graft and survival outcomes
- PMID: 39848339
- DOI: 10.1016/j.ajt.2025.01.014
Association between bariatric surgery after kidney transplantation and graft and survival outcomes
Abstract
Bariatric surgery has been shown to be safe in chronic kidney disease and improves access of patients to transplantation. Whether bariatric surgery after kidney transplantation is associated with improved graft or patient survival has not been examined nationally. We included adults with obesity who received a first kidney transplant according to the US Renal Data System between 2003-2019. We matched 4 controls to each case of bariatric surgery based on age at transplantation, sex, donor type, diabetes, and body mass index at transplantation. We examined the association between bariatric surgery and graft failure or death using multivariable Cox proportional hazards models and Fine-Gray models accounting for death as a competing risk. We included 770 patients, of whom 155 (20%) received bariatric surgery. Median age was 45 years and 56% were women. Receipt of bariatric surgery was associated with improved graft survival (hazard ratio [HR], 0.57; 95% CI, 0.34-0.98) in fully adjusted models, although findings did not consistently maintain statistical significance in competing risk analyses (subHR, 0.60; 95% CI, 0.35-1.02). Receipt of bariatric surgery was associated with lower risk of death (HR, 0.45; 95% CI, 0.26-0.76). In conclusion, bariatric surgery is associated with improved patient survival and potentially graft survival after kidney transplantation.
Keywords: bariatric surgery; graft failure; kidney transportation.
Copyright © 2025 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors of this manuscript have conflicts of interest to disclose as described by American Journal of Transplantation. E.K. reports financial support was provided by NIH. E.K. reports a relationship with Natera, Inc that includes grant funding. E.K. is an Associate Editor at the American Journal of Kidney Diseases. K.L.J. was an Associate Editor at the Journal of the American Society of Nephrology and is a consultant for Vifor. The other authors have no conflicts of interest to disclose as described by American Journal of Transplantation.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
